These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 3009683)

  • 1. Sphingomyelinases and Niemann-Pick disease.
    Levade T; Salvayre R; Douste-Blazy L
    J Clin Chem Clin Biochem; 1986 Apr; 24(4):205-20. PubMed ID: 3009683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New tools for the study of Niemann-Pick disease: analogues of natural substrate and Epstein-Barr virus-transformed lymphoid cell lines.
    Levade T; Salvayre R; Bes JC; Nezri M; Douste-Blazy L
    Pediatr Res; 1985 Jan; 19(1):153-7. PubMed ID: 2982124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingomyelinase and nonspecific phosphodiesterase activities in Epstein-Barr virus-transformed lymphoid cell lines from Niemann-Pick disease A, B and C.
    Levade T; Salvayre R; Lenoir G; Douste-Blazy L
    Biochim Biophys Acta; 1984 Apr; 793(2):321-4. PubMed ID: 6324871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of pyrenesulfonylamido-sphingomyelin and its use as substrate for determining sphingomyelinase activity and diagnosing Niemann-Pick disease.
    Klar R; Levade T; Gatt S
    Clin Chim Acta; 1988 Sep; 176(3):259-67. PubMed ID: 2846208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Importance of fluorescent lipid substrates for the study of hereditary lysosomal lipidoses. Application to the diagnosis of Niemann-Pick disease].
    Douste-Blazy L; Levade T; Salvayre R; Gatt S
    Bull Acad Natl Med; 1988 Jun; 172(6):807-13. PubMed ID: 2847857
    [No Abstract]   [Full Text] [Related]  

  • 6. Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.
    Christomanou H
    Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1489-502. PubMed ID: 6256275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accurate differentiation of neuronopathic and nonneuronopathic forms of Niemann-Pick disease by evaluation of the effective residual lysosomal sphingomyelinase activity in intact cells.
    Graber D; Salvayre R; Levade T
    J Neurochem; 1994 Sep; 63(3):1060-8. PubMed ID: 8051547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A practical chromogenic procedure for the detection of homozygotes and heterozygous carriers of Niemann-Pick disease.
    Gal AE; Brady RO; Hibbert SR; Pentchev PG
    N Engl J Med; 1975 Sep; 293(13):632-6. PubMed ID: 239343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of Niemann-Pick disease using a simple and sensitive fluorimetric assay of sphingomyelinase activity.
    Besley GT
    Clin Chim Acta; 1978 Dec; 90(3):269-78. PubMed ID: 31994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular forms of sphingomyelinase and non-specific phosphodiesterases in Epstein-Barr virus-transformed lymphoid cell lines from Niemann-Pick disease types A and B.
    Levade T; Salvayre R; Douste-Blazy L
    Eur J Biochem; 1985 Jun; 149(2):405-9. PubMed ID: 2986976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biochemical diagnostics of Niemann-Pick disease.
    Maciejko D; Tylki-Szymańska A
    Klin Padiatr; 1986; 198(2):103-6. PubMed ID: 3009958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the activation of sphingomyelinase activity in Niemann-Pick type A, B, and C fibroblasts: enzymological differentiation of types A and B.
    Poulos A; Ranieri E; Shankaran P; Callahan JW
    Pediatr Res; 1984 Nov; 18(11):1088-93. PubMed ID: 6096798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative hydrolysis of sphingomyelin and 2-N-(hexadecanoyl)-amino-4-nitrophenyl-phosphorylcholine by normal human brain homogenate at acid and neutral pH.
    Levade T; Salvayre R; Douste-Blazy L
    J Neurochem; 1983 Jun; 40(6):1762-4. PubMed ID: 6304255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of fluorescent and radiolabelled sphingomyelins in intact cells by a non-lysosomal pathway.
    Levade T; Vidal F; Vermeersch S; Andrieu N; Gatt S; Salvayre R
    Biochim Biophys Acta; 1995 Oct; 1258(3):277-87. PubMed ID: 7548198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann-Pick disease.
    He X; Chen F; Gatt S; Schuchman EH
    Anal Biochem; 2001 Jun; 293(2):204-11. PubMed ID: 11399033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sphingomyelinase activity in a patient with Niemann-Pick disease].
    Sengers RC; Wevers RA; van Haelst UJ; Smeets HL
    Tijdschr Kindergeneeskd; 1989 Apr; 57(2):70-3. PubMed ID: 2545015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake and metabolism of radioactively labeled sphingomyelin in cultured skin fibroblasts from controls and patients with Niemann-Pick disease and other lysosomal storage diseases.
    Kudoh T; Velkoff MA; Wenger DA
    Biochim Biophys Acta; 1983 Nov; 754(1):82-92. PubMed ID: 6626569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new form of Niemann-Pick disease characterised by temperature-labile sphingomyelinase.
    Schneider EL; Pentchev PG; Hibbert SR; Sawitsky A; Brady RO
    J Med Genet; 1978 Oct; 15(5):370-4. PubMed ID: 216805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fluorometric determination of sphingomyelinase by use of fluorescent derivatives of sphingomyelin, and its application to diagnosis of Niemann-Pick disease.
    Gatt S; Dinur T; Barenholz Y
    Clin Chem; 1980 Jan; 26(1):93-6. PubMed ID: 6243257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fluorescence-based, high-throughput sphingomyelin assay for the analysis of Niemann-Pick disease and other disorders of sphingomyelin metabolism.
    He X; Chen F; McGovern MM; Schuchman EH
    Anal Biochem; 2002 Jul; 306(1):115-23. PubMed ID: 12069422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.